280 related articles for article (PubMed ID: 25015740)
21. Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up.
Shaikh AY; LaCombe MA; Du H; Raghavan VT; Nanda RK; Bloomer WD
Radiat Oncol; 2012 Feb; 7():17. PubMed ID: 22309790
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT.
Silverstein MJ; Fastner G; Maluta S; Reitsamer R; Goer DA; Vicini F; Wazer D
Ann Surg Oncol; 2014 Nov; 21(12):3793-9. PubMed ID: 25138079
[TBL] [Abstract][Full Text] [Related]
23. Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience.
Brown A; Buss EJ; Chin C; Liu G; Lee S; Rao R; Taback B; Wiechmann L; Horowitz D; Choi JC; Katz LM; Connolly EP
Front Oncol; 2022; 12():788213. PubMed ID: 35847872
[TBL] [Abstract][Full Text] [Related]
24. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative radiotherapy in elderly patients with breast cancer: Is there a clinical applicability? Review of the current evidence.
Esposito E; Compagna R; Rinaldo M; Falivene S; Ravo V; Amato B; Muto P; D'Aiuto M
Int J Surg; 2016 Sep; 33 Suppl 1():S88-91. PubMed ID: 27255125
[TBL] [Abstract][Full Text] [Related]
26. First Intraoperative Radiation Therapy Center in Africa: First 2 Years in Operation, Including COVID-19 Experiences.
Ramdas Y; Benn CA; van Heerden M
JCO Glob Oncol; 2020 Nov; 6():1696-1703. PubMed ID: 33156717
[TBL] [Abstract][Full Text] [Related]
27. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 1--ELIOT.
Silverstein MJ; Fastner G; Maluta S; Reitsamer R; Goer DA; Vicini F; Wazer D
Ann Surg Oncol; 2014 Nov; 21(12):3787-92. PubMed ID: 25160734
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of selective whole breast irradiation following lumpectomy with intraoperative radiation therapy for hormone receptor positive breast cancer.
Broman K; Sun W; Zhou JM; Fridley B; Diaz R; Laronga C
Am J Surg; 2019 Oct; 218(4):749-754. PubMed ID: 31345502
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively.
Ollila DW; Klauber-DeMore N; Tesche LJ; Kuzmiak CM; Pavic D; Goyal LK; Lian J; Chang S; Livasy CA; Sherron RF; Sartor CI
Ann Surg Oncol; 2007 Feb; 14(2):660-9. PubMed ID: 17091330
[TBL] [Abstract][Full Text] [Related]
31. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
[TBL] [Abstract][Full Text] [Related]
32. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A.
Sperk E; Welzel G; Keller A; Kraus-Tiefenbacher U; Gerhardt A; Sütterlin M; Wenz F
Breast Cancer Res Treat; 2012 Aug; 135(1):253-60. PubMed ID: 22842984
[TBL] [Abstract][Full Text] [Related]
33. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
34. TARGIT-E(lderly)--prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.
Neumaier C; Elena S; Grit W; Yasser AM; Uta KT; Anke K; Axel G; Marc S; Frederik W
BMC Cancer; 2012 May; 12():171. PubMed ID: 22569123
[TBL] [Abstract][Full Text] [Related]
35. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
36. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment.
Kim JW; Cho Y; Choi J; Ahn SG; Jeong J; Lee IJ
Ann Surg Oncol; 2019 Dec; 26(13):4294-4301. PubMed ID: 31520209
[TBL] [Abstract][Full Text] [Related]
37. Factors predictive of failure to complete planned intraoperative breast radiation using the intrabeam® system.
Dossett LA; Abbott AM; Sun W; Loftus L; Lee MC; Diaz R; Laronga C
J Surg Oncol; 2016 Dec; 114(8):930-932. PubMed ID: 27861907
[TBL] [Abstract][Full Text] [Related]
38. Is IORT ready for roll-out?
Esposito E; Anninga B; Honey I; Ross G; Rainsbury D; Laws S; Rinsma S; Douek M
Ecancermedicalscience; 2015; 9():516. PubMed ID: 25793013
[TBL] [Abstract][Full Text] [Related]
39. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
[TBL] [Abstract][Full Text] [Related]
40. [Firs Case Report of Intraoperative Radiotherapy (IORT) for Early Breast Cancer in Bulgaria].
Sedloev T; Gabrovski I; Usheva S; Kovacheva S; Spiridonova T; Spirdonov J; Jeleva Z; Terziev I; Korukov B; Damyanov D; Lövey G
Khirurgiia (Sofiia); 2016; 82(1):40-4. PubMed ID: 29383929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
